Tucker, M. D., Brown, L. C., Chen, Y., Kao, C., Hirshman, N., Kinsey, E. N., . . . Zhang, T. (2021). Association of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma. BMC.
Cita Chicago Style (17a ed.)Tucker, Matthew D., et al. Association of Baseline Neutrophil-to-eosinophil Ratio with Response to Nivolumab Plus Ipilimumab in Patients with Metastatic Renal Cell Carcinoma. BMC, 2021.
Cita MLA (8a ed.)Tucker, Matthew D., et al. Association of Baseline Neutrophil-to-eosinophil Ratio with Response to Nivolumab Plus Ipilimumab in Patients with Metastatic Renal Cell Carcinoma. BMC, 2021.
Precaución: Estas citas no son 100% exactas.